Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease Metadata
Metadata describes a digital item, providing (if known) such information as creator, publisher, contents, size, relationship to other resources, and more. Metadata may also contain "preservation" components that help us to maintain the integrity of digital files over time.
- Main Title Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease
- Series Title Background paper
Author: United States. Congress. Office of Technology Assessment.Creator Type: Organization
Name: United States. Congress. Office of Technology Assessment.Place of Publication: [Washington D.C.]
- Creation: 1992-10
- Content Description: This background paper describes the development of alglucerase, illustrates the role that both the Federal Government and private sector can have in making new therapies available for orphan diseases, and lays out some of the tradeoffs that can exist between developing new medical technologies and controlling health care costs.
- Physical Description: 41 p. : ill. ; 28 cm.
- Library of Congress Subject Headings: Gaucher's disease -- Treatment -- United States.
- Library of Congress Subject Headings: Orphan drugs -- United States.
- Library of Congress Subject Headings: Pharmaceutical policy -- United States.
- Item is not a Primary Source
- Place Name: United States
Name: Office of Technology AssessmentCode: OTA
Name: UNT Libraries Government Documents DepartmentCode: UNTGD
- Accession or Local Control No: 9214
- SuDoc Number: Y 3.T 22/2:2 AL 3
- UNT Catalog No.: b1720993
- Archival Resource Key: ark:/67531/metadc39697